224 results on '"Rashidian, Mohammad"'
Search Results
2. Probing immune infiltration dynamics in cancer by in vivo imaging
3. Development of a Stable Peptide–Major Histocompatibility Complex (MHC) via Sortase and Click Chemistry
4. HIV-infected macrophages resist efficient NK cell-mediated killing while preserving inflammatory cytokine responses
5. Trained Immunity-Promoting Nanobiologic Therapy Suppresses Tumor Growth and Potentiates Checkpoint Inhibition
6. Immuno-PET identifies the myeloid compartment as a key contributor to the outcome of the antitumor response under PD-1 blockade
7. Noninvasive imaging of tumor progression, metastasis, and fibrosis using a nanobody targeting the extracellular matrix : May 8, 2019.
8. In vivo detection of antigen-specific CD8+ T cells by immuno-positron emission tomography
9. Anti–CTLA-4 therapy requires an Fc domain for efficacy
10. Direct and Indirect Regulators of Epithelial–Mesenchymal Transition–Mediated Immunosuppression in Breast Carcinomas
11. Multiparametric Immunoimaging Maps Inflammatory Signatures in Murine Myocardial Infarction Models
12. Data from Nanobody–Antigen Conjugates Elicit HPV-Specific Antitumor Immune Responses
13. Supplementary Figure S6 from Targeting Cytokine Therapy to the Pancreatic Tumor Microenvironment Using PD-L1–Specific VHHs
14. Supplementary Data from Direct and Indirect Regulators of Epithelial–Mesenchymal Transition–Mediated Immunosuppression in Breast Carcinomas
15. Data from Targeting Cytokine Therapy to the Pancreatic Tumor Microenvironment Using PD-L1–Specific VHHs
16. Data from Direct and Indirect Regulators of Epithelial–Mesenchymal Transition–Mediated Immunosuppression in Breast Carcinomas
17. Table S1 from Nanobody–Antigen Conjugates Elicit HPV-Specific Antitumor Immune Responses
18. Figure S1 from Nanobody–Antigen Conjugates Elicit HPV-Specific Antitumor Immune Responses
19. Supplementary Figure Legends from Targeting Cytokine Therapy to the Pancreatic Tumor Microenvironment Using PD-L1–Specific VHHs
20. Supplementary Figure 4 from Epithelial-to-Mesenchymal Transition Contributes to Immunosuppression in Breast Carcinomas
21. Supplementary Figure 6 from Epithelial-to-Mesenchymal Transition Contributes to Immunosuppression in Breast Carcinomas
22. Data from Epithelial-to-Mesenchymal Transition Contributes to Immunosuppression in Breast Carcinomas
23. Supplementary Figure 5 from Epithelial-to-Mesenchymal Transition Contributes to Immunosuppression in Breast Carcinomas
24. Supplementary Figure 3 from Epithelial-to-Mesenchymal Transition Contributes to Immunosuppression in Breast Carcinomas
25. Supplementary Figure 1 from Epithelial-to-Mesenchymal Transition Contributes to Immunosuppression in Breast Carcinomas
26. Supplementary Figure legends from Epithelial-to-Mesenchymal Transition Contributes to Immunosuppression in Breast Carcinomas
27. Supplementary Figure 7 from Epithelial-to-Mesenchymal Transition Contributes to Immunosuppression in Breast Carcinomas
28. Supplementary Figure 2 from Epithelial-to-Mesenchymal Transition Contributes to Immunosuppression in Breast Carcinomas
29. Noninvasive imaging of immune responses
30. Enhanced Tumor Accumulation of Multimodal Magneto‐Plasmonic Nanoparticles via an Implanted Micromagnet‐Assisted Delivery Strategy (Adv. Healthcare Mater. 2/2023)
31. Enhanced Tumor Accumulation of Multimodal Magneto‐Plasmonic Nanoparticles via an Implanted Micromagnet‐Assisted Delivery Strategy
32. Enzymatic Construction of DARPin-Based Targeted Delivery Systems Using Protein Farnesyltransferase and a Capture and Release Strategy
33. Enzymatic Construction of DARPin-Based Targeted Delivery Systems Using Protein Farnesyltransferase and a Capture and Release Strategy
34. Molecular Immune Targeted Imaging of Tumor Microenvironment
35. Converting an anti-mouse CD4 monoclonal antibody into an scFv PET imaging agent for longitudinal monitoring of CD4(+) T cells
36. Direct N- or C-Terminal Protein Labeling Via a Sortase-Mediated Swapping Approach
37. Comparison of thermochemistry of aspartame (artificial sweetener) and glucose
38. Converting an Anti-Mouse CD4 Monoclonal Antibody into an scFv Positron Emission Tomography Imaging Agent for Longitudinal Monitoring of CD4+ T Cells
39. Pustular eruption after biosimilar rituximab infusion: report of acute generalized exanthematous pustulosis in two patients with pemphigus
40. Employing nanobodies for immune landscape profiling by PET imaging in mice
41. Nanobodies for Medical Imaging: About Ready for Prime Time?
42. Abstract PR010: Potentiating the efficacy of immune checkpoint blockade by targeting the epithelial-to-mesenchymal transition (EMT) in breast carcinomas
43. Noninvasive Imaging of Cancer Immunotherapy
44. Direct and Indirect Regulators of Epithelial–Mesenchymal Transition–Mediated Immunosuppression in Breast Carcinomas
45. 623 Immuno-STATs: Leveraging protein engineering to expand and track antigen-specific T cells in vivo
46. 232 The epithelial-to-mesenchymal transition (EMT) contributes to immunosuppression in breast carcinomas and regulates their response to immune checkpoint blockade
47. Treatment of pemphigus patients in the COVID ‐19 era: A specific focus on rituximab
48. Lymphopenia during the COVID-19 infection: What it shows and what can be learned
49. Abstract A82: Direct and indirect regulators of epithelial-to-mesenchymal transition mediated immunosuppression in breast carcinomas
50. Abstract IA15: Noninvasive imaging of immune responses
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.